G. B. Kobaner Et Al. , "Long-term efficacy and safety of ustekinumab for moderate-to-severe psoriasis: A 9-year real-life experience from a tertiary referral center in Turkey," DERMATOLOGIC THERAPY , vol.34, no.4, 2021
Kobaner, G. B. Et Al. 2021. Long-term efficacy and safety of ustekinumab for moderate-to-severe psoriasis: A 9-year real-life experience from a tertiary referral center in Turkey. DERMATOLOGIC THERAPY , vol.34, no.4 .
Kobaner, G. B., Ekinci, A. P., & Kutlay, A., (2021). Long-term efficacy and safety of ustekinumab for moderate-to-severe psoriasis: A 9-year real-life experience from a tertiary referral center in Turkey. DERMATOLOGIC THERAPY , vol.34, no.4.
Kobaner, Goncagül, Algun Polat Ekinci, And Armağan KUTLAY. "Long-term efficacy and safety of ustekinumab for moderate-to-severe psoriasis: A 9-year real-life experience from a tertiary referral center in Turkey," DERMATOLOGIC THERAPY , vol.34, no.4, 2021
Kobaner, Goncagül B. Et Al. "Long-term efficacy and safety of ustekinumab for moderate-to-severe psoriasis: A 9-year real-life experience from a tertiary referral center in Turkey." DERMATOLOGIC THERAPY , vol.34, no.4, 2021
Kobaner, G. B. Ekinci, A. P. And Kutlay, A. (2021) . "Long-term efficacy and safety of ustekinumab for moderate-to-severe psoriasis: A 9-year real-life experience from a tertiary referral center in Turkey." DERMATOLOGIC THERAPY , vol.34, no.4.
@article{article, author={Goncagül BABUNA KOBANER Et Al. }, title={Long-term efficacy and safety of ustekinumab for moderate-to-severe psoriasis: A 9-year real-life experience from a tertiary referral center in Turkey}, journal={DERMATOLOGIC THERAPY}, year=2021}